Wednesday, December 07, 2016

Big Pharma at it again

Drugs giant Pfizer has been fined a record £84.2m by the UK's competition watchdog for overcharging the NHS for an anti-epilepsy drug, Epanutin (phenytoin sodium). 

The Competition and Markets Authority (CMA) also fined distributor Flynn Pharma £5.2m for the 2,600% price increase for the drug in 2012.

NHS spending on the capsules, used by 48,000 UK patients, rose from £2m a year in 2012 to about £50m in 2013. UK prices for the drug were many times higher than in Europe.


0 comments: